PATENT CLAIM ANALYSIS

Application Number: 16211743
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-10
Patent Classification: ["424", "093450"]

Abstract:
This invention relates to new uses of  Bifidobacteria  (particularly, although not exclusively, probiotic  Bifidobacteria ), and to food products, feed products, dietary supplements and pharmaceutical formulations containing them. The bacteria are suitable for the treatment of diabetes (particularly Type 2 diabetes), obesity and related conditions, metabolic syndrome, insulin resistance, and impaired glucose metabolism and consequences thereof, lowering tissue inflammation, treating hepatitis, myositis and cardiovascular conditions.

Claim (Index 58):
The method of  claim 45 , wherein the  Bifidobacterium  and antidiabetic drug are administered in combination with an additional bacterium of the genus  Lactobacillus.

Metadata:
- Claim Count in Document: 104.0
- Percentile: 98.0
- Lexical Diversity: 1.46429
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13384748', '14983827', '15744211', '14457916', '15565317']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.793184784953804
- 35 USC 102 Novelty (BERT): 0.5783429604021213
- Combined Prediction Score: 0.7717006024986357
- Mean Citation Score: 413.4368759999999
- Max Citation Score: 519.724
- Similarity Product: 384.50871687650687

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test